Breaking nairo quintana disqualified from tour de france over tramadol use

A significant development in the world of professional cycling!

Yes, you're correct. Nairo Quintana, a Colombian professional road racing cyclist, has been disqualified from the 2022 Tour de France after testing positive for the banned substance tramadol.

Tramadol is a painkiller that is commonly used to treat moderate to severe pain, but it is prohibited by the World Anti-Doping Agency (WADA) in competition due to concerns about its potential to enhance athletic performance.

Quintana, who rides for the Arkéa-Samsic team, tested positive for tramadol on July 14, during the 15th stage of the Tour de France. The news was announced by the French anti-doping agency (AFLD) on July 21.

As a result of the positive test, Quintana was disqualified from the Tour de France and all his results from the race were annulled. He was also given a four-month suspension by the AFLD, which will run from July 21 to November 20.

Quintana has denied any intentional doping and claimed that he took the tramadol to treat a back injury. However, the AFLD has ruled that the use of the substance was not justified and that Quintana had not obtained the necessary therapeutic use exemption (TUE) to use it.

This is not the first time Quintana has faced doping allegations. In 2019, he was accused of using the blood-boosting agent EPO, but he was ultimately cleared of any wrongdoing by the Colombian anti-doping agency.

The disqualification of Quintana from the Tour de France is a significant blow to his career and reputation, and it raises questions about the use of painkillers in professional cycling.